Filing Details
- Accession Number:
- 0001479290-18-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-16 20:05:54
- Reporting Period:
- 2018-03-16
- Accepted Time:
- 2018-03-16 20:05:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1479290 | Revance Therapeutics Inc. | RVNC | Pharmaceutical Preparations (2834) | 770551645 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635046 | J. Philip Vickers | C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-16 | 2,250 | $31.25 | 5,250 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-03-16 | 900 | $31.20 | 6,150 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
